Literature DB >> 15187167

Defective dendritic cell function in HIV-infected patients receiving effective highly active antiretroviral therapy: neutralization of IL-10 production and depletion of CD4+CD25+ T cells restore high levels of HIV-specific CD4+ T cell responses induced by dendritic cells generated in the presence of IFN-alpha.

Cédric Carbonneil1, Vladimira Donkova-Petrini, Albertine Aouba, Laurence Weiss.   

Abstract

We previously demonstrated that GM-CSF/IFN-alpha combination allowed the differentiation of monocytes from HIV-infected patients into dendritic cells (DCs) exhibiting high CD8(+) T cell stimulating abilities. The present study was aimed at characterizing the ability of DCs generated in the presence of GM-CSF and IFN-alpha to induce CD4 T cell responses. DCs were generated from monocytes of HIV-infected patients in the presence of GM-CSF with either IFN-alpha (IFN-DCs) or IL-4 (IL-4-DCs) for 7 days. Eleven patients receiving highly active antiretroviral therapy and exhibiting CD4 cell counts above 400/mm(3) and plasma HIV-RNA <50 copies/ml for at least 1 year were included in the study. Both DC populations were found to be defective in inducing autologous (in response to tuberculin or HIV-p24) or allogeneic CD4 T cell proliferation. Neutralization of IL-10 during the differentiation of IFN-DCs, but not during the DC-T cell coculture, significantly increased their ability to stimulate autologous CD4 T cell proliferation in response to tuberculin and allogeneic CD4 T cell proliferation (4.1-fold and 3.0-fold increases, respectively, at the DC to T cell ratio of 1:10). Moreover, IL-10 neutralization and CD4(+)CD25(+) T cell depletion synergistically act to dramatically increase HIV-p24-specific CD4 T cell responses induced by IFN-DCs (31.7-fold increase) but not responses induced by IL-4-DCs. Taken together, our results indicate that IFN-DCs are more efficient than IL-4-DCs to stimulate CD4(+) T cell proliferation, further supporting their use for immune-based therapy in HIV infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15187167     DOI: 10.4049/jimmunol.172.12.7832

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

Review 1.  HIV-1 and the hijacking of dendritic cells: a tug of war.

Authors:  Marie Larsson
Journal:  Springer Semin Immunopathol       Date:  2005-01

2.  IL-10 directly suppresses CD4 but not CD8 T cell effector and memory responses following acute viral infection.

Authors:  David G Brooks; Kevin B Walsh; Heidi Elsaesser; Michael B A Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-26       Impact factor: 11.205

3.  Nonhuman Primate Testing of the Impact of Different Regulatory T Cell Depletion Strategies on Reactivation and Clearance of Latent Simian Immunodeficiency Virus.

Authors:  Ranjit Sivanandham; Adam J Kleinman; Paola Sette; Egidio Brocca-Cofano; Sindhuja Murali Kilapandal Venkatraman; Benjamin B Policicchio; Tianyu He; Cuiling Xu; Julia Swarthout; Zhirui Wang; Ivona Pandrea; Cristian Apetrei
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

4.  Interleukin-10 determines viral clearance or persistence in vivo.

Authors:  David G Brooks; Matthew J Trifilo; Kurt H Edelmann; Luc Teyton; Dorian B McGavern; Michael B A Oldstone
Journal:  Nat Med       Date:  2006-10-15       Impact factor: 53.440

5.  Interleukin 23 produced by myeloid dendritic cells contributes to T-cell dysfunction in HIV type 1 infection by inducing SOCS1 expression.

Authors:  Ankita Garg; Pratima Rawat; Stephen A Spector
Journal:  J Infect Dis       Date:  2014-09-18       Impact factor: 5.226

Review 6.  The role of IL-10 in regulating immunity to persistent viral infections.

Authors:  Elizabeth B Wilson; David G Brooks
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

7.  Association of IL-12+ DC with High CD3+CD4-DR+ lymphocyte counts in long-term HIV-infected hemophilia patients with clinically stable disease.

Authors:  Volker Daniel; Cord Naujokat; Mahmoud Sadeghi; Rainer Zimmermann; Angela Huth-Kühne; Gerhard Opelz
Journal:  J Clin Immunol       Date:  2007-09-19       Impact factor: 8.317

8.  CD4+CD25+ regulatory T cells are infected and activated during acute FIV infection.

Authors:  Angela M Mexas; Jonathan E Fogle; Wayne A Tompkins; Mary B Tompkins
Journal:  Vet Immunol Immunopathol       Date:  2008-08-22       Impact factor: 2.046

9.  Conserved T cell and natural killer cell function in treatment-experienced adults receiving tenofovir plus didanosine as nucleoside reverse transcription inhibitor backbone.

Authors:  P Costa; F Bozzano; D Fenoglio; A Beltrame; G Cenderello; A Di Biagio; G Ferrea; G Pagano; A De Maria
Journal:  Clin Exp Immunol       Date:  2009-10       Impact factor: 4.330

10.  Enhanced interferon-gamma secretion and antitumor activity of T-lymphocytes activated by dendritic cells loaded with glycoengineered myeloma antigens.

Authors:  Hong Xiong; Qiu-ye Wu; Hong-gang Hu; Ban Liu; Zhong-wu Guo; Daniel Man-yuan Sze; Jian Hou
Journal:  Chin Med J (Engl)       Date:  2007-10-05       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.